Feasibility study for the application of a point-of-care measurement method for the routine clinical measurement of intraerythrocytic potassium

• Conditions: E87.5; E87.6; Hyperkalaemia; Hypokalaemia

• Registration Number: DRKS00027134
• Lead Sponsor: niversitätsklinikum Gießen und Marburg, Standort Marburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-21
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

Patients 18 years and older
- Persons who are capable of giving consent
- Routine arterial or venous collection of heparin blood

Exclusion Criteria

- Patient refuses to participate in the study
- The patient has already participated in the study
- The patient is already participating in another study during the current stay
- Dementia illness
- No need for arterial or venous blood gas analysis
- Capillary blood gas analysis

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reliability of the POC measurement of the intraerythocytic potassium content

Secondary Outcome Measures

Name	Time	Method
In addition, a descriptive analysis of the reference value of the intracellular potassium value is carried out depending on the following parameters<br>Influence of cardiovascular, endocrinological, gastrointestinal and nephrological pre-existing diseases on the intraerythrocytic potassium content<br>• Influence of medication (including diuretics, antihypertensive drugs) on the intraerythrocytic potassium content